Finance

Beta
Lists
DMAC:NASDAQ
DiaMedica Therapeutics Inc
$7.62
+2.42%
(+0.18) 1D
$7.66
+0.58% (+0.044)
After hours
Closed: Jul 2, 4:00:01 PM GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for DMAC...
Open
$7.46
High
$7.74
Low
$7.27
Mkt. cap
410.59M
Avg. vol.
212.00K
Volume
216.48K
52-wk high
$10.42
52-wk low
$3.55
EPS
-$0.71
Beta
0.98
Shares outstanding
53.88M
No. of employees
35
Open
$7.46
High
$7.74
Low
$7.27
Mkt. cap
410.59M
Avg. vol.
212.00K
Volume
216.48K
52-wk high
$10.42
52-wk low
$3.55
EPS
-$0.71
Beta
0.98
Shares outstanding
53.88M
No. of employees
35
News stories
From sources across the web
About DiaMedica Therapeutics Inc
CEO-
Employees35
Founded2000
HeadquartersMinneapolis, Minnesota, United States
SectorBiotechnology
Websitediamedica.com
Analyst ratings
Based on 3 analysts giving stock ratings to DMAC in the past 3 months
Strong buy
Buy
3
Hold
0
Sell
0
12-month forecast
Based on 3 Wall Street analysts offering 12 month price targets for DMAC in the last 3 months.
Highest
Current $7.62
$14.00 (+83.73%)
Average
$13.00 (+70.60%)
Lowest
$12.00 (+57.48%)
Analyst
Recommendation
Action
Price target
Projected
Date
Chase Knickerbocker
Craig-Hallum
Buy
Maintained
-
-
06/24/2026
Thomas Flaten
Lake Street
Buy
Reiterated
$14.00
+83.7%
06/23/2026
Eric Martinuzzi
Lake Street
Buy
Maintained
$14.00
+83.7%
05/08/2026
Matthew Caufield
H.C. Wainwright
Buy
Reiterated
$12.00
+57.5%
05/08/2026
Ben Haynor
Lake Street
Buy
Maintained
$14.00
+83.7%
04/01/2026
Joshua Schimmer
Cantor Fitzgerald
Buy
Maintained
$25.00
+228.1%
01/21/2026
Previous reportsAll values in CAD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Revenue
-
-
-
-
Cost of goods sold
-
-
-
-
Cost of revenue
-
-
-
-
Research and development expenses
5.82M
6.44M
6.70M
7.99M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
2.18M
2.60M
2.51M
2.50M
Operating expense
8.01M
9.03M
9.21M
10.48M
Total operating expenses
8.01M
9.03M
9.21M
10.48M
Operating income
-8.01M
-9.03M
-9.21M
-10.48M
Other non operating income
314.00K
419.00K
-1.18M
-
EBT including unusual items
-7.69M
-8.61M
-8.73M
-10.04M
EBT excluding unusual items
-7.69M
-8.61M
-8.73M
-10.04M
Income tax expense
6.00K
6.00K
10.00K
7.00K
Effective tax rate
-0.08%
-0.07%
-0.11%
-0.07%
Other operating expenses
-
-
-
-
Net income
-7.70M
-8.62M
-8.74M
-10.04M
Net profit margin
-
-
-
-
Earnings per share
-0.18
-0.17
-0.17
-0.19
Interest and investment income
-
-
1.66M
447.00K
Interest expense
-
-
-
-
Net interest expenses
-
-
1.66M
447.00K
Depreciation and amortization charges
-
-
-
-
EBITDA
-8.00M
-9.02M
-9.20M
-10.47M
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

What's on your mind?
What's going on with the markets today?
Explore what’s possible
Deep Search
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer